# LUNESTA
> **NDA021476** · New Drug Application · Sponsor: WAYLIS THERAP · Approved 2004-12-15
## Drug
- **FDA Application Number:** NDA021476
- **Application type:** New Drug Application
- **Brand name:** LUNESTA
- **Generic name:** ESZOPICLONE
- **Active ingredients:** ESZOPICLONE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** WAYLIS THERAP
- **Manufacturer:** Waylis Therapeutics LLC
- **First approval:** 2004-12-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021476)
---
*MORVS · CC0 1.0*